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Essential fatty acids (EFA) are those fatty acids which animals cannot synthesize 
in amounts adequate for proper growth, maintenance and functioning of many 
physiological processes 2. There are two common essential fatty acids, linoleic acid 
[9,12-octadecadienic acid; 18:2 (n-6)] and arachidonic acid [5,8,11,14-eicosatetra- 
enoic acid; 20:4 (n-6)], which adequately alleviate the symptoms of EFA deficiency 
in pathologic or experimentally induced conditions i. Linoleic acid is a precursor of 
arachidonic acid and is converted to the latter by A6 &saturation of linoleic acid 
to-,I-linolenic acid [ 18 : 3 (n-6) ] followed by chain elongation to dihomo-y-linolenic 
acid [20:3 (n-6)] and then by &5 &saturation to arachidonic acid 3. Arachidonic 
acid is a precursor of the dienoic series of prostaglandins such as prostaglandin (PG) 
H2, E2, F2, D2, I2 (prostacyclin), and thromboxane A2. The monoene series of pro- 
staglandins, such as PGE,, is derived from dihomo-,/-linolenic acid 3,36 
Tissues from essential fatty acid deficient animals ~s,38 contain low levels of lino- 
leic, linolenic and arachidonic acids and increased accumulation of 5,8,11-eicosatrie- 
noic acid [20:3 (n-9)] and oleic acid [18:1 (n-9)]. The (n-9)-type of fatty acid, 
eicosatrienoic acid and oleic acid, are not substrates for prostaglandin synthesis 3s 
Investigation of essential fatty acid deficiency in animals, first described by BuRR 
and BURR 8 and by HOLMAN 19, has so far been restricted mostly to nutritional 
studies. Recent reports have, however, indicated the usefulness of EFA deficiency in 
the study of the roles of prostaglandins in pathophysiology. Prostaglandin synthesis 
has been reported to be suppressed in experimentally induced essential fatty acid 
deficiency in rats 28. BONTA et al. 4 reported suppression of prostaglandin-mediated 
carrageenin-induced hind paw inflammation in EFA-deficient rats due to shortage 
of prostaglandin precursors. EFA deficiency in rats has beeff used to study the 
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roles of prostaglandins in acute s,22 and chronic inflammatory processes 6,11,27 and to 
discriminate prostaglandin and non-prostaglandin-mediated components of inflam- 
mation 4. 
A variety of prostaglandins affect various endocrine secretory functions including 
the endocrine control of sugar homeostasis 39. FSH and LH secretion from rat pitui- 
tary is enhanced by PGE2 and PGF2~ 17,z~. The stimulation of gonadotropin release 
by prostaglandins is explained to be exerted directly on the hypothalamo-pituitary 
unit as well as mediated by actions on the gonads 9.16. Stimulation of thyroxine release 
by thyrotropin may be mediated by prostaglandins 26. The possible role of prosta- 
glandins in the regulation of pancreatic endocrine secretion and in the etiology of 
diabetes mellitus has been investigated. Prostaglandins were first reported to affect 
insulin secretion in 1968 7. Although evidence implicating prostaglandins as insulin 
secretagogues is conflicting, the stimulatory effects of administered prostaglandins 
on glucagon secretion appear to be consistent. In the isolated perfused rat pancreas, 
reports a0,31,32 show that in the presence of glucose (5.6 mmol/1), PGEI PGE_, and 
PGF2, evoked biphasic release of glucagon and insulin. Recently, we have reported 
that prostaglandin endoperoxide, PGH2, is a secretagogue for glucagon and insulin 
(equipotent with the classical prostaglandins, PGE2 and PGF2,) and also that 
thromboxane (TXA2 and TXB,_) and prostacyclin (PGI2), were not effective secreta- 
gogues, whereas PGD2 is a more potent stimulant of glucagon than insulin secretion 5. 
A comprehensive assessment of the current reported effects of prostaglandins on 
insulin and glucagon secretion is available in our recent publication 2 and that of 
ROBERTSON 33. In the present study , isolated pancreata from rats deficient in essential 
fatty acids were perfused to ascertain the role of prostaglandin precursors in the 
endocrine pancreas secretory response to insulin and glucagon secretagogues. 
MATERIALS AND METHODS 
Weanling albino rats of the Sprague-Dawley strain were maintained for 16 weeks 
on a diet deficient in essential fatty acids (Nutritional Biochemical) and housed under 
controlled conditions of humidity, light and temperature. Food and water were 
available ad libitum. Control rats received standard laboratory chow. The principal 
apparent manifestations of essential fatty acid deficiency were diminished growth 
rate and scaly dermatitis, mainly on the feet and tail. The animals were anesthetized 
with sodium pentobarbital (50 mg/kg) injected i.p. and the pancreas with its 
intact vasculature was removed and transferred to an extracorporeal perfusion 
apparatus as described previously 3,. The perfusion solution contained 120 mmol/1 
NaC1, 4.7 retool/1 KC1, 0.8 mmol/l MgSO4, 2.4 mmol/1 CaC12, 1.2 mmol/1 KH2PO4, 
25 mmol/1 NaHCO3, 5.6 mmol/1 D-glucose, 56 ~mol/1 dextran and 30 ~mol/l 
bovine serum albumin. The perfusion flow rate was kept constant at 2.5 ml/min. 
Perfusion pressure was monitored continuously using a pressure transducer, an 
amplifier, and a strip-chart recorder. After a 30-min equilibration period, the 
experimental protocol was commenced. 
The perfusion system employs four independent perfusion channels connecting 
four corresponding reservoirs which merged into a manifold to which the aortic 
cannula was connected. With the use of four independent perfusion channels, 
individual test agents contained in each reservoir can be diverted to perfuse the 
pancreas via a common aortic cannula. L-arginine monohydrochloride (ICN) (10 
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mmol/1), L-leucine (Sigma) (10 retool/l) or bovine growth hormone (NIH) (100 
~tmol/l) were dissolved in the basic perfusion medium and added shortly before 
the experiments to the appropriate reservoir and equilibrated at 37 ~ with a 
mixture of 95% oxygen and 5% carbon dioxide. Depending on the experimental 
protocol, rat pancreata were perfused with each secretagogue (with the exception 
of glucose) for 1 rain, separated by a 15-min period, during which the pancreata 
were perfused with basic buffer solution only. Perfusion media contained 5.6 
mmol/1 glucose at all times. A solution containing 16.7 retool/1 D-glucose was 
perfused for 30 min. The pancreatic portal venous effluent was collected in l-rain 
fractions; the samples were chilled immediately, aliquoted for  submission to 
radioimmunoassays, and stored at -20 ~ until the time of assay. 
Radioimmunoassays for glucagon and insulin were performed using the 'double- 
antibody' method described previously 29. Beef-pork glucagon and rat insulin were 
used as standards in the respective assays. The 5-min total response areas (where 
applicable) were computed as described previously 29.34. The amounts of hormone 
secreted in this time period were derived by multiplying the concentration of each 
1-min sample by the flow rate and summing these values for the 5-min interval. 
The statistical significance of differences between observed values was determined 
by two-tailed Student's t-test. Values are given as mean -+- SEM. 
One-hundred-milligram pieces of tissue, pancreas, liver, heart, lung, kidney and 
skeletal muscle excised from EFA deficient rats and control rats (pancreas only) 
were homogenized for 20 sec in chloroform/methanol (2:1, v/v) and acidified with 
formic acid. The homogenate was heated to 70 ~ for 10 min, cooled and centrifuged. 
The organic phase was separated and extracted with formic acid according to the 
procedure of FOLCH et al. 13 and then methylated with 8% concentrated sulfuric 
acid in methanol. The methyl esters were analyzed by means of gas-liquid chromato- 
graphy (Varian 3700) on a 10% diethylene glycol succinate (DEGS-PS) glass 
column at 185 ~ using a flame-ignition detector (FID). Fatty acid esters were 
identified by use of pure standards. The peak areas were quantified by an automatic 
digital integrator (Varian). The fatty acid values are expressed as mol % (mean 
-+- SEM). 
RESULTS 
Fatty acid levels o / E F A  deficient rats - Tab. 1 summarizes data on fatty acid 
content of pancreata obtained from control rats and EFA deficient rats. These rats 
were similar to those used in isolated pancreas perfusion to assess hormone release. 
It can be clearly seen that the level of oleate (18:1, n-9) was significantly lower 
in the control rats than in the EFA-deficient rats. The increased level of oleate 
which is a non-essential fatty acid, is probably due to preferential accumulation 
during essential fatty acid deficiency. Eicosatrienoic acid (20:3, n-9) which like 
oleate is a non-prostaglandin precursor, was present in trace amounts in control rats, 
but was significantly elevated in EFA-deficient rats. On the contrary, arachidonic 
acid (20:4, n-6) and linoleic acid (18:2, n-6) which can serve as substrates for 
prostaglandin synthesis 3,36 were higher in control rats (15 • 2 and 19 -+- 3, respec- 
tively) but were present only in trace amounts in EFA-deficient rats (1.6 -+- 0.5 
and 1.0-----0.4, respectively). Whereas the triene:tetraene (20:3, n-9720:4, n-6) 
ratio was very low (0.027) as would be expected, this ratio was 8.8 in EFA-deficient 
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rats, which represents approximately 15,000% increase over the control (tab. 1). 
The high triene:tetraene ratio is indicative of severe EFA deficiency and is compa- 
rable to ratios previously reported by other investigators 11,1s,19, 27 
In tab. 2 are shown data on fatty acid content of various organs obtained 
from EFA-deficient rats prior to perfusion of pancreata to ascertain hormone 








control rats (n = 4) 
2 8 •  
24-1 
14 4- 0.4 
12 -.4- 0.8 
1 9 •  
0.4 4- 0.3 
1 5 •  
EFA-deficient rats (n = 3) 
28-.4-4 
8-.4- 0.5 
7.2 -4- 0.9 
38~--2 
1+--.0.4 
1 4 •  
1.6 ----- 0.5 
total fatty acids 69.0 -.4- 2 74.0 • 1 
(nmol/mg) 
triene/tetraene ratio * 0.027 -.4- 0.01 8.8 • 2 
* 20:3, n-9/20:4, n-6 ratio 
Tab. 1 - Mean mole percent ( +  SEM) fatty acid content of control and EFA-deficient rat pancreata. 
Values were computed as percent of total nmol fatty acid per mg tissue for (n) observations 











(n = 4) 
24 •  
64-_1 
17.3 -4- 2 
31.5 -4- 1 
0.9 • 0.2 




(n = 3) 
2 6 •  
1 0 •  
7.3-.4-2 
42-.4-2 
1.1 -.4- 0.2 
13.3 -.4- 3 
1 .4  -.4- 0.6 
adipose 
tissue 
(n = 2) 
2 4 •  
19• 
2"4"0.1 
52 _--4- 0.4 
9-----0.1 
heart 
(n = 4) 
12---1 
3"4"1 
23.2 • 3 
27 •  
1.2 -4- 0.1 
24.1 • 3 
3.5 -.4- 0.6 
lung 







0.8 -.4- 0.1 
kidney 
(n = 2) 
28"4"1 
5-----0.2 
21 -- 0.5 
25.3 • 0.2 
0.7-.4- 0 
9.2 -.4- 0.4 
3.54.0.1 
total 
fatty acids 104 -4- 5 84 -- 13 309 -.4- 31 57 -.4- 1 49 --- 1 47 --- 2 
Inmol/mg) 
triene/tetraene 
ratio * 3.5 -- 2 9.5 -.4- 5 - -  6.9 • 5 7.5 -.4- 1 2.63 <- 4 
* 20:3, n-9/20:4, n-6 ratio 
Tab. 2 - Mean mole percent ( •  SEM) fatty acid content of various organs obtained from EFA 
deficient rats prior to perfusion of pancreata to ascertain hormone release. Values were computed 
as percent of total nmole fatty acid per mg tissue for (n) observations calculated with the method 
of FOLCH et al. 13. 
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6 ;0 ~ a'0 
min 
Fig. 1 - Each point represents mean -+- SEM of either insulin secretion in EFA-deficient rats 
(n--D, n=6) and control rats (o--o, n=4) or glucagon secretion (m--m, n=6)in EFA-deficient 
rats and ( . - - . ,  n=4) in control rats. 
release. As in tab. 1, the levels of non-prostaglandin precursor fatty acids such as 
18:1, n-9 and 20:3, n-9 were high in all the organs measured. These values were 
comparable to those reported in the literature for severely EFA-deficient animals 15. ~9 
In contrast, the prostaglandin-precursor fatty acids (20:4, n-6 and 18:2, n-6) were 
present in trace amounts. The triene:tetraene (20:3, n-9/20:4, n-6) ratios were 
as follows: liver 3.5 --+--- 2; skeletal muscle 9.5 • 5; heart 6.9 ----+- 5; lung 7.5 ----+- 1 
and kidney 2.6 • 4. These high ratios are evidence of severe essential fatty acid 
deficiency and suppressed endogenous prostaglandin synthesis m.13.z7 
Glucose-stimulated glucagon and insulin secretion - Fig. 1 illustrates the dynamics 
of insulin and glucagon secretion in response to an increase in the concentration of 
glucose from 5.6 to 16.7 mmol/1. The pattern of the insulin secretory response to 
glucose 16.7 mmol/1 perfused for 30 min was biphasic both in control and EFA- 
deficient rats. The glucose stimulated acute secretion (phase I) was significantly 
greater (p<0.01) in magnitude and amplitude in EFA-deficient (open circles) than 
in the control rats (open squares). There was no significant difference in the second 
phase of glucose-stimulated insulin secretion between the two groups. There was, 
however, a slow return to nadir following phase-1 secretion in the EFA-deficient 
rats. This probably was a normal elution decay in view of the greater amounts of 
phase-1 insulin in EFA-deficient rats compared to control rats. Glucagon secretion 
in the control and EFA-deficient rats was inhibited as would be expected by high 
glucose concentration. 
Glucagon and insulin secretion in response to common secretagogues - Tab. 3 
summarizes data on glucagon and insulin secretory response to 1-min perfusions 
of pancreata isolated from EFA-deficient and control rats with L-arginine (10 
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retool/l), bovine growth hormone (100 ~mol/1) or L-leucine (10 mmol/1). Glucagon 
secretion in response to arginine was not significantly-different in control and EFA- 
deficient rats (1,647 • 591 vs 1,223 ----- 233, respectively). However, the magnitude 
of arginine-stimulated insulin release was significantly higher in EFA-deficient than 
in control rats (5,309 ----- 863 vs 2 ,665  +- 357). Growth hormone-induced secretion 
was variable in the two groups. Whereas bGH-induced gluca~n release was much 
higher in the control rats, insulin secretion was significantly higher in EFA-deficient 
rats. Glucagon and insulin secretion in response to L-leucine was minimal but 
significantly higher than basal secretion (428-----42 vs 49 • 11, glucagon; 233 
---+ 88 vs 60 • 18, insulin). There was no corresponding observation of leucine 
effect in the control rats. 
DISCUSSION 
Prostaglandins and related arachidonic acid metabolites are ubiquitous in animal 
tissues and regulate a variety of biological processes, including hormone secretion. 
Administered prostaglandins and inhibitors of prostaglandin synthesis modify the 
secretion of glucagon and insulin, often with conflicting results, as previously re- 
viewed 2,33. The purpose of the present investigation was to determine the effect of 
suppressed or deprived prostaglandin synthesis upon insulin and glucagon secretion 
in response to common secretagogues. Data summarized in tabs 1 and 2 convincingly 
indicate severe EFA deficiency in our animal model. In the pancreas of the EFA- 
deficient rats, the ratio of trienoic to tetraenoic fatty acids was 8.8. A condition 
of EFA deficiency in rats with triene/tetraene ratios of 4 or greater has been 
reported to result in progressive suppression of prostaglandin synthesis 28. Prosta- 
glandin production by platelets obtained from EFA deficient rats was suppressed 
relative to the degree of EFA-deficiency 28. C~AWrORD et al. 13 have shown that 
PGEI, PGE2 and PGE2~ content of tissues from EFA-deficient rabbits was signifi- 
cantly lower than in normal rabbits. In these rabbits, there was a corresponding 
decrease in linoleic and dihomo-y-linolenic acids, fatty acids which are substrates for 
prostaglandin synthesis. Our fatty acid data presented in tabs 1 and 2 are consistent 
with those previously reported ,3 
glucagon (fmol/5 rain) insulin (fmol/5 rain) 
agents 








4 2 •  (n = 8) 
16472-'591 (n = 4) 
22352--94 ( n = 4 )  
49--- 11 (n = 6) 
1223• = 8) 
327---44 ( n = 8 )  
428• ( n = 4 )  
28• ( n = 8 )  
2665 ---- 357(n = 4) 
75-----8 ( n = 4 )  
60-----18 ( n = 6 )  
53092863(n=  8) 
252-----56 ( n = 7 )  
233• ( n = 4 )  
Tab. 3 - Values represent 5-rain cumulative portal effluent glucagon (fmol/5 min) and insulin 
(fmol/5 min) secretion following l-rain peffusion with agents indicated. The amount of hormone 
released in the subsequent 5 min is given as the mean +_ SEM for the number of experiments 
indicated in parentheses. 
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The high triene/tetraene ratio (8.8) in EFA-deficient rats compared to 0.027 
in the controls (tab. 1) indicates that there was little or no arachidonate in the 
EFA-deficient rats. In corollary, there was no substrate for prostaglandin synthesis, 
and hence, no potential for any significant synthesis of prostaglandins. 
Our results on hormone release illustrated in fig. 1 demonstrate a slightly 
augmented secretory function of the islets of Langerhans in EFA deficiency. However, 
the similar pattern and dynamics of glucagon secretion in both the control and 
EFA-deficient rats suggest a non-mandatory regulatory role of prostaglandins in 
endocrine pancreas secretion. The enhanced magnitude of phase-1 (acute phase) 
insulin release induced by glucose in EFA-deficient rats as compared to controls, 
probably indicates a possible inhibitory effect of prostaglandins 33. As shown in tab. 3, 
glucagon and insulin secretory response to secretagogues such as bGH and leucine 
which induce hormone release by mechanism(s) possibly different and unrelated 34 
was unaltered by EFA deficiency. There was significantly enhanced arginine- 
stimulated insulin secretion in the EFA-deficient rats. 
The present observations by no means pose logical contradiction to our pre- 
viously reported stimulation by exogenously administered prostaglandins in isolated 
perfused pancreas 2'29'3~ However, the mechanism(s) by which administered 
prostaglandins elicit hormone release could be different and unrelated to the actions 
of the endogenous prostaglandins. Prostaglandins are a very potent and active 
class of lipids and could probably modify hormone release in in vitro conditions 
such as the perfused pancreas without any obligatory regulation of endocrine 
pancreas secretion. 
The mechanism by which administered prostaglandins modulate the secretory 
activity of endocrine glands is often attributed to interaction of their specific mem- 
brane receptors with adenylate cyclase ~0.20, since prostaglandins generally elevate the 
level of cyclic AMP in tissues and affect metabolic functions regulated by cyclic 
AMP. The stimulant effect of prostaglandins on endocrine secretion also seems to 
involve alteration in intracellular calcium concentrations m,20, although HERTELENDY 
et al. 2, reported that the prostaglandins do not act as ionophores. The pharmaco- 
logical effects of administered prostaglandins could involve direct action on the cell 
membrane. MISHIMA and KURIYAMA 18 reported depolarization of guinea pig 
stomach longitudinal muscle membrane by PGEb PGE2, or PGE2~, suggesting that 
these prostaglandins may increase calcium influx by stimulating electrical activity 
of the membrane. Changes in membrane depolarization with the associated calcium 
influx in response to pancreatic endocrine hormone secretagogues is a well-established 
phenomenon. 
Several reports show that inhibitors of prostaglandin synthesis augment or 
stimulate secretion of insulin i2.14,24. These observations indicate that endogenous 
prostaglandins may have an inhibitory role on insulin secretion. Our data in fig." 1" 
demonstrating an enhanced phase-1 glucose-stimulated insulin secretion in EFA- 
deficient rat are in agreement with the concept of an inhibitory role of endogenous 
prostaglandins. MACADAMS et al. 23 observed augmentation of stimulated insulin 
secretion from isolated perfused pancreas when the donor rats had been pretreated 
with nictindole (L8027, a combined inhibitor of cyclooxygenase and thromboxane 
synthase) and indomethacin had been added to the perfusion solutions 37. 
We have provided evidence that the secretory function of the endocrine pancreas 
is operational in EFA deficiency, a condition in which there is deficiency of sub- 
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strates for prostaglandin synthesis. O u r  studies may exempli fy  the  lack of an 
obl igatory  role of prostaglandins  in insulin and glucagon secretion. The  use of 
EFA-def ic ient  animals as a model  for the s tudy of the role of pros taglandins  in 
endocrine pancreas and other  endocr ine  gland secretions could resolve the  conflic- 
t ing findings concerning the effects of prostaglandins .  
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SUMMARY 
Insulin and glucagon secretion in response to common secretagogues were ascertained in 
the perfused pancreas isolated from essential fatty acid deficient rats. The pattern of insulin 
secretory response to glucose (16.7 retool/l) by isolated rat pancreas perfused for 30 rain was 
hiphasic in EFA-deficient and control rat pancreas. The amplitude of glucose-stimulated acute 
secretion (phase I) was significantly greater (p<0.01) in magnitude and amplitude in EFA-deficient 
rats than in the control rats. There was no significant difference in the second phase of glucose- 
stimulated insulin secretion in the two groups. Glucagon secretion in EFA-deficient and control 
rats was inhibited by glucose (16.7 retool/l). Glucagon secretion induced by L-arginine (10 
retool/l) was not significantly different in EFA-deficient and in control rat pancreata (p>0.05). 
However, arginine (10 mmol/1)-stimulated insulin release was significantly higher in EFA-deficient 
than in control rats. Growth hormone (100 Bmol/l)-induced glucagon and insulin secretion was 
variable in the two groups but significantly higher than basal secretion. The level of L-leucine 
(10 mmol/1)-stimulated glucagon and insulin secretion in EFA-deficient rats was minimal but 
significant. Our results show that isolated pancreata of rats devoid of precursors for endogenous 
prostaglandin synthesis secreted insulin and glucagon in response to common secretagogues. 
On the basis of our data, it is concluded that endogenous prostaglandins are probably not obligatory 
for normal secretory functions of islets of Langerhans. 
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